GTENU — Gores Holdings X, Inc. / CI
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 1986817 ·
Last close
$10.49
Market Cap
—
52W High
$10.60
52W Low
$10.33
ADV30
460
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -189,862 | 6,147,078 | 371,721,370 | 431,326 | 29,233,641 |
| Dec 2025 | 0 | — | -1,283,339 | 868,956 | 368,717,492 | 619,576 | 32,376,841 |
| Sep 2025 | 0 | — | -339,102 | 1,843,616 | 365,470,067 | 208,222 | 29,998,372 |
| Jun 2025 | 0 | — | -276,708 | -1,737,874 | 361,967,135 | 320,648 | 28,340,118 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,229,315
Investing CF
$569,464
Financing CF
$359,888,403
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-28,225,314
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-2,089,011
Pretax Income TTM
$7,121,776
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,953,188 | 920,659 | 368,717,492 | 32,376,841 | — | -1,041,065 |
| Dec 2024 | 0 | 0 | 0 | 1,184,632 | 1,224,632 | — | -52,901 |
| Dec 2023 | — | — | — | 924,034 | 964,034 | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $4.89B | $38.29 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $642.10M | $10.08 | — |
| BCSS | Bain Capital GSS Investment Corp. | $479.79M | $10.23 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $477.69M | $10.18 | — |
| CEPF | Cantor Equity Partners IV, Inc. | $474.15M | $10.33 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.